It is recommended that people aged 60 or older get vaccinated during this campaign. KAMARERO
With the beginning of autumn many things come. The opening of the school year, the drop in temperatures, the shortening of the days, the change of wardrobe to warmer clothes… and the most dangerous thing: a greater spread of infectious diseases, especially seasonal respiratory viruses that reproduce at higher rates. speed and survive better at low temperatures. That is why, every year at this time, the vaccination campaign against influenza is activated, the most feared of these diseases, to which, since the Covid-19 pandemic, the coronavirus has also joined. Next week, the war against these two will begin. A war that last year resulted in 720,492 people vaccinated, which represents 30.31% of the Community’s population. A percentage that was somewhat lower in Segovia, with 28.96% after 44,546 people received doses.
On October 3, the vaccination campaign against these viruses will begin in Castilla y León with institutionalized people (that is, those who live in centers such as residences) and on October 10 it will do so with the general population in the groups in which which is recommended. For the 2023-2024 campaign, the Ministry of Health has purchased 805,500 doses of flu vaccines, about 54,000 of them for Segovia. The total expenditure is 10,527,058 euros, including a new intranasal vaccine intended for the child population from 24 to 59 months.
Regarding influenza, the campaign will be aimed at those population groups with a higher risk of complications if they suffer from influenza infection and at people who can transmit it to others with a high risk of complications. Meanwhile, the objective of vaccination against Covid-19 is to reinforce the protection of the most vulnerable people and health and social health personnel to reduce mortality and the impact of this disease on healthcare capacity.
RECOMMENDED GROUPS
Although vaccination is not mandatory for the general population, the Board does recommend it to different groups, starting with people 60 years of age or older and those with more than 5 inmates in disability centers and nursing homes, as well as others. people institutionalized for a long time and residents in closed institutions. This last group would be the one with which vaccination will begin on day 3.
On the other hand, and within those under 60 years of age, vaccination is recommended for people with risk conditions such as diabetes, chronic cardiovascular, neurological or respiratory diseases, asthma, anemia, hemophilia, HIV, cancer and malignant hemopathies and diseases that entail cognitive dysfunction, such as Down syndrome, dementia and others. Also included are cohabitants with these groups, pregnant women, and healthcare and essential public service personnel (police officers and firefighters, among others).
Children between 24 and 59 months will receive the flu vaccine intranasally.
The novelty in the immunization calendar of Castilla y León this year is the child population between 6 and 59 months of age. Children between 6 and 23 months will receive the vaccine intramuscularly while those between 24 and 59 will receive it intranasally (good news for those afraid of needles). Likewise, the Board recommends vaccination for staff in educational centers, those who present a higher risk of complications derived from the flu (including smokers), internship students in health centers and workers on farms, poultry, swine or mink farms or who They are in contact with wildlife.
VACCINES AND ADMINISTRATION
The flu vaccines available in Castilla y León correspond to five types (see table), which will be received weekly at the different vaccination points: the tetravalent inactivated vaccine ‘Vaxigrip’ is intended, preferably, for the healthy population between 6 and 23 months and 60 and 64 years, as well as people at risk; the adjuvanted tetravalent inactivated vaccine ‘Fluad tetra’, for the non-institutionalized general population aged 65 or over; the tetravalent inactivated units with high antigenic load ‘Efluelda’, intended for institutionalized population over 60 years of age and large dependents in their homes; the tetravalent inactivated vaccines ‘Flucelvax tetra’, for people allergic to antibiotics; the tetravalent attenuated vaccine ‘Fluenz tetra’, administered intranasally and whose target population is children between 24 and 59 months.
Doses of flu vaccines to be distributed by provinces
On the other hand, the vaccine that will be administered against Covid-19 is monovalent against a subvariant of the omicron strain, one of the most dangerous. The goal is to obtain protection against circulating strains of SARS-CoV-2 (the virus that causes said disease). Until the last week of October, Castilla y León will receive from the Ministry of Health just over 400,000 doses of Coronavirus vaccines (27,000 for Segovia), which are received weekly. So far, some 26,000 doses have arrived at the Territorial Health Services, almost 400 in our province.
Regarding the administration of the vaccines, people institutionalized in residences will receive both doses from health professionals from each health area of Castilla y León who will go to these centers. Their presence will be used to also vaccinate the professionals who work there. On the other hand, health and social health personnel will be able to get vaccinated in their workplaces, through the reference occupational health services. For the rest of the population aged 60 and over or under 60 with risk factors, the places where they can be vaccinated and the appointment method will be established in each health area. The appointment can be requested a few days before October 10 through the Sacyl Conecta App, the telephone number of your health center and on the Castilla y León Health Portal.
BRONCHIOLITIS
Another novelty in the Immunization Calendar of Castilla y León is the incorporation of the new drug ‘Nirsevimab’ that provides immunity against the Respiratory Syncytial Virus (RSV), whose infection causes bronchiolitis. In Castilla y León, a single dose of Niservimab will be administered during the 2023-2024 campaign for all children born between March 1, 2023 and March 31, 2024.
Depending on the date of birth, the administration will be carried out in the hospital or health center: those born on or after October 1 will receive the monoclonal antibody in the hospital at birth, while those born between March and September will receive the monoclonal antibody in the hospital at birth. A specific campaign will be carried out at the beginning of the RSV season, during the month of October, administering the dose at the usual health center or vaccination center.
Additionally, Nirsevimab will be administered to the infant population at high risk of severe RSV disease, including premature infants less than 35 weeks (a single dose before 12 months of age), patients with congenital heart disease, bronchopulmonary dysplasia, or with severe immunosuppression. In the latter three, ‘Nirsevimab’ will be administered before each RSV season, before reaching 24 months of age, at the time of receiving immunization.
Dosage of ‘Nirsevimad’ drug for bronchiolitis
For this immunization, 13,000 doses have been purchased, 950 in Segovia, at a cost of 2,825,680 euros.
2023-09-30 03:30:09
#vaccination #campaign #flu #Covid19 #begins #receive #doses #Adelantado #Segovia
